Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 22:16:51 - browse：4

hazy pages of aetna.com layered next to each other, as shown through a kaleidoscopic glass — Adobe

CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which could potentially drive away 10% of its membership, the company’s chief financial officer said at an investment banking conference Tuesday.

“The goal for next year is margin over membership,” CVS CFO Tom Cowhey said at the conference, hosted by Bank of America. “Could we lose up to 10% of our existing Medicare members next year? That’s entirely possible. And that’s OK, because we need to get this business back on track.”

CVS, through its Aetna subsidiary, is the third-largest Medicare Advantage insurer, with more than 4.2 million enrollees as of April, according to the latest federal data. That means next year CVS could push out up to 420,000 older adults and people with disabilities on its Medicare Advantage plans, forcing them to choose another plan.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Drugmakers bet big on mRNA for cancer. Why's Biden going in?

knowledge

WSS

AstraZeneca loses challenge to Medicare drug price negotiation

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Wegovy improves function in certain heart failure patients

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Study: Spinal cord stimulation helps patients with paralysis walk again

PBMs are inflating the cost of generic drugs. They must be reined in

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

Sports medicine is finally prioritizing gender equality

Trans patients at the end of life deserve respect and dignity

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Former Pear Therapeutics executives start new VC firm

After affirmative action ruling, medical educators look to 'holistic review'

Medical device lobby: We're tired of waiting on Medicare coverage

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How to fix the rural physician shortage in the U.S.

ChatGPT in medicine: STAT answers readers' burning questions

Roche's accidental data boosts hopes for anti

explore

DeSantis wants to import drugs. Biden’s FDA blasted his plan

California store owner shot dead in dispute over displaying Pride flag: Police

How to fix the rural physician shortage in the U.S.

Former Pear Therapeutics executives start new VC firm

Change Healthcare cyberattack outage could last weeks

In search for therapies for solid tumors, companies turn to claudin

explore

entertainment

knowledge

focus